Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.97B | 32.58B | 31.65B | 30.59B | 29.38B | 29.02B | Gross Profit |
13.41B | 13.16B | 12.86B | 12.52B | 11.93B | 11.04B | EBIT |
4.28B | 4.24B | 4.31B | 4.43B | 4.28B | 3.54B | EBITDA |
8.20B | 7.93B | 7.57B | 7.50B | 7.34B | 6.71B | Net Income Common Stockholders |
3.23B | 3.12B | 3.13B | 3.02B | 3.04B | 2.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.20B | 7.17B | 10.87B | 12.80B | 14.22B | 14.57B | Total Assets |
38.35B | 66.88B | 58.81B | 55.90B | 53.41B | 49.92B | Total Debt |
0.00 | 0.00 | 1.30B | 1.10B | 587.00M | 1.03B | Net Debt |
-9.20B | -7.17B | -9.57B | -11.70B | -13.63B | -13.54B | Total Liabilities |
3.71B | 7.15B | 5.33B | 4.89B | 5.34B | 5.24B | Stockholders Equity |
34.63B | 59.73B | 53.48B | 51.01B | 48.07B | 44.68B |
Cash Flow | Free Cash Flow | ||||
1.92B | -765.00M | -961.00M | 1.06B | 2.72B | 2.23B | Operating Cash Flow |
1.92B | 1.14B | 524.00M | 2.20B | 3.15B | 2.50B | Investing Cash Flow |
0.00 | -3.81B | -1.43B | -3.25B | -3.15B | -3.49B | Financing Cash Flow |
0.00 | -1.03B | -1.02B | -377.00M | -351.00M | -163.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $3.25T | 9.75 | 12.68% | 2.70% | 2.93% | -8.11% | |
76 Outperform | $2.17T | 9.91 | 11.53% | 3.66% | 30.62% | 8.49% | |
70 Outperform | ¥102.77B | 24.41 | 0.92% | 6.18% | 3.45% | ||
64 Neutral | $4.43B | 12.01 | 5.16% | 249.23% | 4.03% | -11.73% | |
64 Neutral | €180.72B | 19.27 | 5.23% | 3.35% | 9.51% | -69.64% | |
61 Neutral | $1.44T | 11.53 | 13.61% | 2.56% | 27.41% | 214.53% | |
57 Neutral | ¥194.59B | 11.09 | 4.46% | -4.62% | 17.56% |